Inhibition of HCV by the serpin antithrombin III

BACKGROUND: Although there have been dramatic strides made recently in the treatment of chronic hepatitis C virus infection, interferon-α based therapy remains challenging for certain populations, including those with unfavorable IL28B genotypes, psychiatric co-morbidity, HIV co-infection, and decom...

Descripción completa

Detalles Bibliográficos
Autores principales: Asmal, Mohammed, Seaman, Michael, Lin, Wenyu, Chung, Raymond T, Letvin, Norman L, Geiben-Lynn, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519617/
https://www.ncbi.nlm.nih.gov/pubmed/23031791
http://dx.doi.org/10.1186/1743-422X-9-226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519617/
https://www.ncbi.nlm.nih.gov/pubmed/23031791
http://dx.doi.org/10.1186/1743-422X-9-226

Ejemplares similares